Episode 48: Meet CONTINUUS Pharmaceuticals chief business officer, Bayan Teisho Takizawa (MA-USA)
Manage episode 290089616 series 2880471
CONTINUUS Pharmaceuticals is a spin out from the Novartis-MIT Center for CONTINUUS Manufacturing, an $85 joint research endeavor. We are leveraging a novel manufacturing platform call Integrated Continuous Manufacturing, or ICM. With ICM, we were able to take a 200-day manufacturing process and cut it down to just two days. There were additional benefits in costs, footprint, environmental impact, and quality. https://www.continuuspharma.com
Follow CONTINUUS Pharmaceuticals
https://www.linkedin.com/company/continuus-pharmaceuticals/
https://twitter.com/continuusp
Learn about CONTINUUS Pharmaceuticals
https://www.businesswire.com/news/home/20190905005168/en/CONTINUUS-Pharmaceuticals-Raises-5-Series-Led-Mark
https://www.youtube.com/watch?v=NShPYlvgSt4
https://www.youtube.com/watch?v=zD2-9papmOA
https://www.youtube.com/watch?v=WniRiVZb9Ts
201 episodes